BeStock  
Stocks › Biotechnology › ONC

BeiGene ONC

US equityMarket cap rank #365Biotechnology
$362.25 −$3.69 (-1.01%)
Market open · Oct 1, 11:50 am ET · After hours $365.94 0.00%
Open$367.94
Prev close$365.94
Day range$361.63 – $371.02
Volume106.7K
Market cap$41.19B
P/E (TTM)64.1
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings64.8x
CheapRich

Near the top of its 5-year range · 85th percentile, 5-year average 25.6x

#2651 of 2977 stocks by PE (1 = cheapest)

Price / book8.0x
CheapRich

Above its usual level · 73rd percentile, 5-year average 6.4x

#4736 of 5307 stocks by PB (1 = cheapest)

Price / sales6.8x
CheapRich

Below its usual level · 24th percentile, 5-year average 12.4x

#4147 of 5144 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$392.18
Price vs. fair value-7.6%Trading below the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 8.04 – 6.36 73% (pricier than usual) #4736 of 5307 (1 = cheapest)
PE 64.77 44.23 25.61 85% (pricier than usual) #2651 of 2977 (1 = cheapest)
PS 6.79 5.77 12.36 24% (cheaper than usual) #4147 of 5144 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$392.18
Economic moatNarrow
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on ONC.

Leave a comment

Scroll to Top